Inventaire - your friends and communities are your best library

The varied distribution and impact of RAS codon and other key DNA alterations across the translocation cyclin D subgroups in multiple myeloma

author

Charlotte Pawlyn

Faith E Davies

Brian A. Walker

Gareth J Morgan

published in: Oncotarget

date of publication: 2017-02-24

language: English

Cites articles 38

Date

Title

Authors

2016-01-25

Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL.
2016-08-11

Clonal selection and double-hit events involving tumor suppressor genes underlie relapse in myeloma

Brian A. Walker, Cody Ashby, Michael A Bauer, Tobias Meißner, Faith E Davies, Gareth J Morgan, Frits van Rhee
2015-08-17

Mutational Spectrum, Copy Number Changes, and Outcome: Results of a Sequencing Study of Patients With Newly Diagnosed Myeloma

Brian A. Walker, Eileen M Boyle, Christopher P Wardell, Charlotte Pawlyn, Annamaria Brioli, Ana Quartilho, G. C. Cook, Gareth J Morgan
2015-04-23

APOBEC family mutational signatures are associated with poor prognosis translocations in multiple myeloma

Brian A. Walker, Christopher P Wardell, Eileen M Boyle, Charlotte Pawlyn, David C Johnson, G. C. Cook, Gareth J Morgan
2015-02-25

Removing batch effects from purified plasma cell gene expression microarrays with modified ComBat

Bart Barlogie
2015-04-20

limma powers differential expression analyses for RNA-sequencing and microarray studies

Matthew E Ritchie, Belinda Phipson, Gordon K Smyth
2014-07-01

The MAPK pathway as an apoptosis enhancer in melanoma

Manfred Schartl
2013-08-01

Cdks, cyclins and CKIs: roles beyond cell cycle regulation

Philipp Kaldis
2013-08-30

Long-term follow-up of MRC Myeloma IX trial: Survival outcomes with bisphosphonate and thalidomide treatment.
2012-05-01

A comprehensive survey of Ras mutations in cancer

Ian A. Prior
2012-04-23

Whole-genome sequencing of multiple myeloma from diagnosis to plasma cell leukemia reveals genomic initiating events, evolution, and clonal tides

Jonathan J Keats, Sumit Middha, Rafael Fonseca
2012-04-12

The genetic architecture of multiple myeloma

Gareth J Morgan, Brian A. Walker
2011-11-04

Cyclophosphamide, thalidomide, and dexamethasone as induction therapy for newly diagnosed multiple myeloma patients destined for autologous stem-cell transplantation: MRC Myeloma IX randomized trial results
2010-05-01

A critical role for the NFkB pathway in multiple myeloma
2010-09-30

Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myeloma

Bart Barlogie, Dirk Hose, Hartmut Goldschmidt
2010

Regularization Paths for Generalized Linear Models via Coordinate Descent

Robert Tibshirani, Trevor Hastie, Jerome H. Friedman
2010-06-07

Pattern of retinoblastoma pathway inactivation dictates response to CDK4/6 inhibition in GBM

Lynda Chin, William C Hahn
2010-01-06

Classical and/or alternative NF-kappaB pathway activation in multiple myeloma

Adriana Zingone
2010-06-23

Gene expression profiling for molecular classification of multiple myeloma in newly diagnosed patients

Dirk Hose, Pieter Sonneveld, Hartmut Goldschmidt, Sonja Zweegman, Henk M. Lokhorst, Bronno van der Holt
2009-08-06

The molecular characterization and clinical management of multiple myeloma in the post-genome era.
2008-06-05

Clinical and biological significance of RAS mutations in multiple myeloma

S. Vincent Rajkumar, Rafael Fonseca
2007-08-01

Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma

Bart Barlogie
2007-01-01

Dusp6 (Mkp3) is a negative feedback regulator of FGF-stimulated ERK signaling during mouse development
2006-01-01

A comparison of statistical tests for detecting differential expression using Affymetrix oligonucleotide microarrays

Sujoy Ghosh
2006-05-25

The molecular classification of multiple myeloma

Frits van Rhee, Bart Barlogie, Shmuel Yaccoby, Elias Anaissie, Maurizio Zangari
2006-01-12

Comparison of Affymetrix GeneChip expression measures

Zhijin Wu, Rafael Irizarry
2005-09-01

Molecular pathogenesis and a consequent classification of multiple myeloma
2005-03-08

Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma

Bart Barlogie
2005-10-01

Delineation of distinct subgroups of multiple myeloma and a model for clonal evolution based on interphase cytogenetics

Hartmut Goldschmidt
2004-08-15

Different mechanisms of cyclin D1 overexpression in multiple myeloma revealed by fluorescence in situ hybridization and quantitative analysis of mRNA levels

Leticia Quintanilla-Martinez, Karin Bink, Falko Fend
2004-02-01

Genetics and cytogenetics of multiple myeloma: a workshop report.

Rafael Fonseca, Bart Barlogie
2003-12-25

The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma

Bart Barlogie

Article - wd:Q33709470

Welcome to Inventaire

the library of your friends and communities

learn more